Valneva SE
EPA:VLA.PA
Overview | Financials
Company Name | Valneva SE |
Symbol | VLA.PA |
Currency | EUR |
Price | 2.652 |
Market Cap | 430,028,902 |
Dividend Yield | 0% |
52-week-range | 2.466 - 7.168 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Thomas Lingelbach |
Website | https://valneva.com |
An error occurred while fetching data.
About Valneva SE
Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD